Clinical trial
A Prospective Non-interventional Study (Nis) Of The Routine Use Of Etanercept In The Long-term Treatment Of Patients With Plaque-type Psoriasis In Everyday Practice: An Efficacy, Safety, And Health Economic Evaluation
NCT00708708 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Non-interventional Study (Nis) Of The Routine Use Of Etanercept In The Long-term Treatment Of Patients With Plaque-type Psoriasis In Everyday Practice: An Efficacy, Safety, And Health Economic Evaluation
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- December 31, 2013
- Enrollment
- 926 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.